David Ebersman: From Corporate Finance to Mental Healthcare Entrepreneurship
David Ebersman has built a corporate career spanning financial research, biotechnology executive leadership, digital communications, and digital healthcare. As co-founder and chief executive officer of Lyra Health, Ebersman guides an enterprise dedicated to transforming access to behavioral support services. Before founding his own healthcare organization, Ebersman directed fiscal strategy and operational growth for major corporations, navigating public stock markets and overseeing large enterprise teams across diverse industries.
Academic Background and Early Financial Roles
Ebersman prepared for his executive career through studies in international relations and economics, graduating from Brown University in June 1991 with an AB degree. He began his professional path later that year in September 1991, joining Oppenheimer & Co, Inc. as a research analyst. This role allowed Ebersman to develop analytical frameworks for assessing markets and organizational performance. He remained at Oppenheimer & Co, Inc. until February 1994, building a foundation in financial analysis before transitioning into executive management roles within the biotechnology industry.
Corporate Leadership at Genentech and Facebook
In February 1994, Ebersman moved to biotechnology company Genentech, where he spent fifteen years ascending through executive positions. By 2006, he was named executive vice president and chief financial officer of Genentech, holding these top positions until 2009. Seeking new corporate leadership challenges, Ebersman joined Facebook as chief financial officer in September 2009. Recruited specifically for his background managing public corporate finances, he directed the company’s financial policy during an era of significant growth. His leadership culminated in guiding Facebook through its initial public offering on May 18, 2012, which stood as the largest United States internet public offering in history at the time. He continued to lead Facebook’s financial operations until stepping down in June 2014, when David Wehner succeeded him.
Enterprise Growth at Lyra Health
Drawing on his executive experience across biotechnology and technology platforms, Ebersman launched Lyra Health in May 2015 as a mental health care startup. Serving as co-founder and chief executive officer, Ebersman set out to construct a dedicated framework for delivering mental care solutions. Under his executive guidance, Lyra Health grew rapidly, scaling its business model and achieving an overall valuation of 4.6 billion dollars by 2021. Ebersman continues to lead the organization as chief executive officer, guiding its strategic trajectory within the healthcare sector.
Board Leadership and Governance Roles
In addition to his direct management responsibilities at Lyra Health, Ebersman has extended his influence across corporate oversight. He serves on the board of directors for Castlight Health, bringing his expertise in healthcare and corporate finance to board decisions. Furthermore, Ebersman serves on the board of directors at SurveyMonkey, where he holds the position of chairman of the board. Through these key positions, he influences strategy, oversight, and governance across software and healthcare organizations.
Sources
Written by Icon Magazine from these sources, and fact-checked against them.
Keep reading
More profiles

Healthcare · 22 November 2026
Unlocking the Genome: A Founder's Quest for Rapid DNA Sequencing
Jonathan Rothberg — Founder, 454 Life Sciences

Healthcare · 21 November 2026
Wang Jun's Quest for a Digitalized Life Through Health Data
Wang Jun — founder and CEO, iCarbonX
Healthcare · 20 November 2026
Shantha Biotechnics: A Founder's Healthcare Journey
K. I. Varaprasad Reddy — founder of vaccine manufacturing company, Shantha Biotechnics